MediGate: a MedTech product innovation development process from university research to successful commercialization within emerging markets

Pravee Kruachottikul, Pinnaree Tea-makorn (), Poomsiri Dumrongvute, Solaphat Hemrungrojn, Natawut Nupairoj, Ornsiree Junchaya and Sukrit Vinayavekhin
Additional contact information
Pravee Kruachottikul: Faculty of Medicine, Chulalongkorn University
Pinnaree Tea-makorn: Chulalongkorn University
Poomsiri Dumrongvute: Chulalongkorn University
Solaphat Hemrungrojn: Faculty of Medicine, Chulalongkorn University
Natawut Nupairoj: Chulalongkorn University
Ornsiree Junchaya: Milken Institute School of Public Health, The George Washington University
Sukrit Vinayavekhin: Thammasat University

Journal of Innovation and Entrepreneurship, 2024, vol. 13, issue 1, 1-43

Abstract: Abstract This study proposes a comprehensive MedTech product innovation development framework tailored for university research commercialization within emerging markets. The MediGate framework, built on the Augmented Stage-Gate model, addresses the unique challenges of MedTech innovation, including regulatory compliance, stakeholder engagement, and market dynamics. The framework integrates critical decision-making criteria for different types of inventions to drive academic research toward commercialization in clinical settings. Through detailed case studies, including innovations like albumin strip test, 3D-printed patient-specific implant, COVID-19 nasal spray, and AI platform for depression detection, and iterative refinement, the framework provides actionable guidelines for navigating the complexities of product development. These guidelines ensure alignment with clinical needs, regulatory requirements, and market strategies. The research highlights the importance of early-stage valuation, reimbursement strategies, legal and IP considerations, and manufacturing and quality management. By offering a structured pathway, this research contributes to the theoretical and practical understanding of MedTech commercialization, aiming to enhance innovation success and healthcare impact in emerging markets.

Keywords: Entrepreneurship; New product development; Innovation; MedTech; Digital health; Medical devices; Research commercialization; Technology transfer; Regulatory compliance; Intellectual property; Venture creation; Innovation-driven enterprise; Financial valuation; Clinical readiness level (search for similar items in EconPapers)
Date: 2024
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1186/s13731-024-00439-8 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:joiaen:v:13:y:2024:i:1:d:10.1186_s13731-024-00439-8

Ordering information: This journal article can be ordered from
https://innovation-e ... ip.springeropen.com/

DOI: 10.1186/s13731-024-00439-8

Access Statistics for this article

Journal of Innovation and Entrepreneurship is currently edited by Elias G. Carayannis

More articles in Journal of Innovation and Entrepreneurship from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().